已收录 268921 条政策
 政策提纲
  • 暂无提纲
The Novel Anti-Rheumatic Drug TA-383 Has a Macrophage Migration Enhancing Activity
[摘要] References(15)Cited-By(4)We have investigated the effect of a novel anti-rheumatic drug, cis-2-(4-chlorophenyl)-4, 5-diphenyl-2-imidazoline hydrochloride (TA-383), on macrophages. TA-383 (≥10-9 M)significantly stimulated rabbit alveolar macrophage (AM)migration, and its migration-stimulatory activity was more potent than those of L-fucose (5 × 10-3 M), lobenzarit disodium, bucillamine (SA-96)and salazosulfapyridine. In addition, TA-383 enhanced the production and/or release of macrophage migration enhancement factor by rabbit spleen cells. In vivo, TA-383 (0.4 mg/kg, p.o.)has suppressive effects on picryl chloride-induced delayed type hypersensitivity and type II collagen-induced arthritis in mice. These results suggest that the anti-rheumatic activity of TA-383 may be exerted through the dispersion of macrophages from inflammatory sites.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词] TA-383;Macrophage migration enhancement activity;Collagen-induced arthritis [时效性] 
   浏览次数:5      统一登录查看全文      激活码登录查看全文